Potential Target for Skin Cancer Treatment

Key points
- Scientists at the UVa Cancer Center have studied melanoma tumors from patients at various stages of the disease over the last few years.
- Newswise - When normal skin cells become a melanoma tumor, they sometimes turn on genes not usually found in the skin.
- The genes, called cancer-testis antigens, could be useful targets for drugs that could selectively kill a melanoma tumor, while sparing the rest of the body's tissues.
- "Scientists are beginning to see patterns in the profile of genes expressed in individual tumor cells," said John C.
Scientists at the UVa Cancer Center have studied melanoma tumors from patients at various stages of the disease over the last few years. They discovered that more than half of these tumors made the cancer-testis antigens, called SPANX proteins. Herr and his UVa research team showed that the SPANX proteins play a role in the formation of the nuclear envelope of the developing human spermatid.
Newswise - When normal skin cells become a melanoma tumor, they sometimes turn on genes not usually found in the skin. According to researchers at the University of Virginia Health System, some of these genes are normally active in the male testis at the time sperm are formed.
The genes, called cancer-testis antigens, could be useful targets for drugs that could selectively kill a melanoma tumor, while sparing the rest of the body's tissues. The antigens could also help researchers develop a vaccine to stimulate the immune system to attack and suppress melanoma tumors.
"Scientists are beginning to see patterns in the profile of genes expressed in individual tumor cells," said John C. Herr, Ph.D., professor of cell biology at UVa and a scientist at the UVa Cancer Center. " Patients who express a given cancer-testis antigen may eventually be helped by such selective therapies. This scenario represents one aspect of the growing opportunities envisioned for personalized medicine."
Scientists at the UVa Cancer Center have studied melanoma tumors from patients at various stages of the disease over the last few years. They discovered that more than half of these tumors made the cancer-testis antigens, called SPANX proteins. In a study published in the Sept. 29, 2006 online edition of the Journal Molecular Human Reproduction, Herr and his UVa research team showed that the SPANX proteins play a role in the formation of the nuclear envelope of the developing human spermatid. The paper can be found online at this link: http://molehr.oxfordjournals.org/cgi/content/abstract/gal079.
"The SPANX proteins appear at the last stages of sperm production, " explained Anne Westbrook, Ph.D., lead author of the study and a researcher in UVa's department of biochemistry and molecular genetics. "Interestingly, the SPANX proteins remain restricted to regions of the nuclear envelope that do not touch the acrosome, an organelle involved in fertilization."
Researchers at the University of Virginia Health System first identified and named the SPANX gene family in 2000. "UVa continues to make strides in understanding select areas of the human genome," Herr said. "Although the X chromosome on which these genes lie is often associated with determination of female gender, in this case the X chromosome contains genes involved in formation of the sperm. This gene family is now attracting considerable interest from other groups."
For example, scientists at the National Cancer Institute recently discovered that the SPANX family represents one of the most rapidly evolving regions of the human genome. The five SPANX genes appear to have evolved by gene duplication from a single common ancestor since the rise of hominoids. African great apes like chimpanzees, bonobos, gorillas, and orangutans have SPANX, but monkeys do not.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBrachytherapy: Targeted Breast Cancer Treatment Comes With Risks
An increasing number of women are treating their breast cancer with brachytherapy, a type of radiation therapy that delivers a smaller, more targeted dose of radiation. But a new study suggests that the treatment might…
2 May 2012
NewsNew Lung Cancer Treatment Target Identified By Scientists
According to a new study, researchers from the Salk Institute of Biological Studies, California, have discovered that medication used on an inflammation specific enzyme could create a new treatment scheme for certain…
18 February 2012
NewsTargeting PTEN May Prevent Skin Cancer
Scientists believe they have identified a role for PTEN, a known tumor suppressor, in removing DNA damage derived from UVB radiation, a known risk factor for non-melanoma skin cancer, according to a study published in…
27 July 2011





